PT85468A - Pharmaceutical formulations - Google Patents

Pharmaceutical formulations

Info

Publication number: PT85468A
Authority: PT; Portugal
Prior art keywords: pharmaceutical formulations; formulations; pharmaceutical
Prior art date: 1986-08-01

Application number

PT85468A

Other languages

Portuguese (pt)

Other versions

PT85468B (en

Inventor

Brian Anthony Carlin

John Norman Healey

Graham Stanley Leonard

Geoffrey David Tovey

Original Assignee

Smith Kline French Lab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1986-08-01

Filing date

1987-07-31

Publication date

1987-08-01

1987-07-31 Application filed by Smith Kline French Lab filed Critical Smith Kline French Lab

1987-08-01 Publication of PT85468A publication Critical patent/PT85468A/en

1990-06-29 Publication of PT85468B publication Critical patent/PT85468B/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/45—Non condensed piperidines, e.g. piperocaine having oxo groups directly attached to the heterocyclic ring, e.g. cycloheximide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

PT85468A 1986-08-01 1987-07-31 PROCESS FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS BASED ON CIMETHYDIN PT85468B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB868618847A GB8618847D0 (en)	1986-08-01	1986-08-01	Pharmaceutical formulations

Publications (2)

Publication Number	Publication Date
PT85468A true PT85468A (en)	1987-08-01
PT85468B PT85468B (en)	1990-06-29

Family

ID=10602097

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PT85468A PT85468B (en)	1986-08-01	1987-07-31	PROCESS FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS BASED ON CIMETHYDIN

Country Status (22)

Country	Link
US (1)	US4996222A (en)
EP (1)	EP0257823B1 (en)
JP (1)	JPH0643304B2 (en)
KR (1)	KR960012397B1 (en)
CN (1)	CN1024497C (en)
AU (1)	AU601206B2 (en)
CA (1)	CA1287802C (en)
DE (1)	DE3778795D1 (en)
DK (1)	DK149988D0 (en)
EG (1)	EG18388A (en)
ES (1)	ES2037086T3 (en)
GB (1)	GB8618847D0 (en)
GR (1)	GR3005298T3 (en)
HU (1)	HU205853B (en)
IE (1)	IE60759B1 (en)
IL (1)	IL83349A (en)
MY (1)	MY100998A (en)
PH (1)	PH23505A (en)
PT (1)	PT85468B (en)
WO (1)	WO1988000825A1 (en)
ZA (1)	ZA875631B (en)
ZW (1)	ZW13587A1 (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HU196775B (en) *	1986-08-05	1989-01-30	Richter Gedeon Vegyeszet	Process for production of morfologically unique new modifications of famotidin and medical compositions containing such substances
NL8902338A (en) *	1988-09-20	1990-04-17	Glaxo Group Ltd	PHARMACEUTICAL PREPARATIONS.
GB9127150D0 (en) *	1991-12-20	1992-02-19	Smithkline Beecham Plc	Novel treatment
US5272137A (en) *	1992-02-14	1993-12-21	Mcneil-Pfc, Inc.	Aqueous pharmaceutical suspension for pharmaceutical actives
NO941358L (en) *	1993-04-16	1994-10-17	Mcneil Ppc Inc	Aqueous pharmaceutical suspension and process for preparation thereof
AU3154895A (en) *	1994-08-01	1996-03-04	Kv Pharmaceutical Corporation	Tastemasked liquid pharmaceutical delivery system
GB2298365B (en) *	1995-03-03	1997-05-07	Reckitt & Colmann Prod Ltd	A liquid pharmaceutical composition alginate and potassium bicarbonate
GB9504599D0 (en) *	1995-03-03	1995-04-26	Reckitt & Colmann Prod Ltd	Improvements in or relating to organic compositions
GB9708772D0 (en) *	1997-04-30	1997-06-25	Reckitt & Colmann Prod Ltd	Organic compositions
BR9809310A (en) *	1997-04-30	2000-07-04	Reckitt & Colmann Prod Ltd	Spillable liquid liquid composition, pharmaceutical compositions and processes for the treatment of reflux esophagitis, gastritis, dyspepsia or peptic ulceration, and to form a protective coating on the gastrointestinal mucosa tissue, pharmaceutical composition in solid unit dosage form.
IN186245B (en)	1997-09-19	2001-07-14	Ranbaxy Lab Ltd
US6287693B1 (en) *	1998-02-25	2001-09-11	John Claude Savoir	Stable shaped particles of crystalline organic compounds
US6132758A (en) *	1998-06-01	2000-10-17	Schering Corporation	Stabilized antihistamine syrup
GB9930058D0 (en) *	1999-12-20	2000-02-09	Novartis Ag	Organic compounds
US6515008B1 (en) *	2000-05-04	2003-02-04	Smithkline Beecham Corporation	Formulation
DE10224086A1 (en) *	2002-05-31	2003-12-11	Bayer Ag	Pharmaceutical preparations for oral use containing ion-exchange resins loaded with active substance and structurally viscous gel formers as thickeners
US6930119B2 (en) *	2002-07-17	2005-08-16	Reliant Pharmaceuticals, Inc.	Liquid pharmaceutical composition
JP2006519659A (en) *	2003-03-10	2006-08-31	ザ・リージェンツ・オブ・ジ・ユニバーシティ・オブ・ミシガン	Alginate dural sealant compositions and methods of use
CN101052308A (en) *	2004-11-02	2007-10-10	普拉克生化公司	Method for stabilizing and preventing coagulation of proteins in milk
US20060094760A1 (en) *	2004-11-04	2006-05-04	Fawzy Abdel A	Composition, system and method of treatment of gastrointestinal disorders with nizatidine oral solution
ATE396710T1 (en) *	2005-07-19	2008-06-15	Ethypharm Sa	GASTRORETENTIVE COMPOSITIONS AND METHOD FOR PRODUCING
FR2911506B1 (en) *	2007-01-18	2009-07-03	Ceva Sante Animale Sa	PHARMACEUTICAL COMPOSITIONS FOR ORAL ADMINISTRATION IN THE FORM OF STABILIZED AQUEOUS SUSPENSIONS
US8999395B2 (en) *	2007-02-09	2015-04-07	Ceva Sante Animale	Pharmaceutical compositions for oral administration in the form of stabilised aqueous suspensions
RU2012113844A (en) *	2009-09-10	2013-10-20	Биал-Портела Энд К.А., С.А.	ORAL SUSPENSION MEDICINAL FORMS OF ESELICARBAZEPINE ACETATE
GB201918617D0 (en) *	2019-12-17	2020-01-29	Reckitt Benckiser Health Ltd	Personal lubricant composition
WO2024231881A2 (en) *	2023-05-09	2024-11-14	Minoryx Therapeutics S.L.	Polymorphic forms and formulations of leriglitazone

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS56104868A (en) *	1980-01-24	1981-08-20	Fujimoto Seiyaku Kk	Conversion between polymorphous crystals of cimetidine
HU185457B (en) *	1981-09-25	1985-02-28	Richter Gedeon Vegyeszet	Process for preparating cimetidine-z
CA1239349A (en) *	1983-10-10	1988-07-19	Eberhard F. Gottwald	Pharmaceutical composition containing cimetidine

1986
- 1986-08-01 GB GB868618847A patent/GB8618847D0/en active Pending
1987
- 1987-07-22 ZW ZW135/87A patent/ZW13587A1/en unknown
- 1987-07-27 MY MYPI87001138A patent/MY100998A/en unknown
- 1987-07-27 IL IL83349A patent/IL83349A/en not_active IP Right Cessation
- 1987-07-27 CA CA000543046A patent/CA1287802C/en not_active Expired - Lifetime
- 1987-07-28 PH PH35588A patent/PH23505A/en unknown
- 1987-07-29 EP EP87306731A patent/EP0257823B1/en not_active Expired - Lifetime
- 1987-07-29 DE DE8787306731T patent/DE3778795D1/en not_active Expired - Lifetime
- 1987-07-29 KR KR1019880700331A patent/KR960012397B1/en not_active Expired - Lifetime
- 1987-07-29 WO PCT/GB1987/000539 patent/WO1988000825A1/en not_active Ceased
- 1987-07-29 JP JP62504716A patent/JPH0643304B2/en not_active Expired - Lifetime
- 1987-07-29 HU HU874205A patent/HU205853B/en unknown
- 1987-07-29 AU AU77564/87A patent/AU601206B2/en not_active Expired
- 1987-07-29 ES ES198787306731T patent/ES2037086T3/en not_active Expired - Lifetime
- 1987-07-30 EG EG439/87A patent/EG18388A/en active
- 1987-07-30 ZA ZA875631A patent/ZA875631B/en unknown
- 1987-07-31 IE IE207787A patent/IE60759B1/en not_active IP Right Cessation
- 1987-07-31 PT PT85468A patent/PT85468B/en unknown
- 1987-07-31 CN CN87105387A patent/CN1024497C/en not_active Expired - Lifetime
1988
- 1988-03-18 DK DK149988A patent/DK149988D0/en not_active Application Discontinuation
1990
- 1990-03-09 US US07/490,851 patent/US4996222A/en not_active Expired - Lifetime
1992
- 1992-07-29 GR GR920401630T patent/GR3005298T3/el unknown

Also Published As

Publication number	Publication date
EP0257823B1 (en)	1992-05-06
CN87105387A (en)	1988-02-17
AU601206B2 (en)	1990-09-06
JPH01500434A (en)	1989-02-16
CA1287802C (en)	1991-08-20
MY100998A (en)	1991-06-29
EG18388A (en)	1992-10-30
KR880701551A (en)	1988-11-03
IL83349A (en)	1992-03-29
US4996222A (en)	1991-02-26
CN1024497C (en)	1994-05-18
AU7756487A (en)	1988-02-24
EP0257823A1 (en)	1988-03-02
DK149988A (en)	1988-03-18
JPH0643304B2 (en)	1994-06-08
DK149988D0 (en)	1988-03-18
GB8618847D0 (en)	1986-09-10
HUT46541A (en)	1988-11-28
IE60759B1 (en)	1994-08-10
DE3778795D1 (en)	1992-06-11
KR960012397B1 (en)	1996-09-20
GR3005298T3 (en)	1993-05-24
PT85468B (en)	1990-06-29
IE872077L (en)	1988-02-01
ES2037086T3 (en)	1993-06-16
ZA875631B (en)	1989-03-29
ZW13587A1 (en)	1989-02-15
HU205853B (en)	1992-07-28
WO1988000825A1 (en)	1988-02-11
PH23505A (en)	1989-08-16

Publication	Publication Date	Title
GB2196964B (en)	1990-07-18	Pharmaceutical compositions
GB8610572D0 (en)	1986-06-04	Pharmaceutical preparation
GB8716904D0 (en)	1987-08-26	Stable pharmaceutical preparation
GB8618847D0 (en)	1986-09-10	Pharmaceutical formulations
GB8608818D0 (en)	1986-05-14	Pharmaceutical compositions
GB2191696B (en)	1991-01-16	Pharmaceutical compositions
CS8700282A2 (en)	1991-07-16	Nicorandil-containing stable pharmaceutical
GB2190838B (en)	1990-12-12	Pharmaceutical compositions
GB2187953B (en)	1989-11-15	Pharmaceutical formulation
GB8623389D0 (en)	1986-11-05	Pharmaceutical formulations
GB2188235B (en)	1990-11-14	Pharmaceutical compositions
GB8721313D0 (en)	1987-10-14	Pharmaceutical preparation
ZA876048B (en)	1988-04-27	Pharmaceutical formulation
GR871915B (en)	1988-04-05	Pharmaceutical formulations
GB8615041D0 (en)	1986-07-23	Pharmaceutical compositions
ZA876959B (en)	1988-05-25	Pharmaceutical formulations
GB8603097D0 (en)	1986-03-12	Pharmaceutical formulations
GB8603031D0 (en)	1986-03-12	Pharmaceutical formulations
GB8720485D0 (en)	1987-10-07	Pharmaceutical formulations
GB8707419D0 (en)	1987-04-29	Pharmaceutical formulations
GB8708527D0 (en)	1987-05-13	Pharmaceutical formulations
GB8707420D0 (en)	1987-04-29	Pharmaceutical formulations
GB8707418D0 (en)	1987-04-29	Pharmaceutical formulations
GB8723862D0 (en)	1987-11-11	Pharmaceutical formulations
GB8707417D0 (en)	1987-04-29	Pharmaceutical formulations